Share of Cost, Gastric Bypass Cuts Diabetes, Cardiovascular, Health Risks
Monday, May. 13th 2013 8:13 AM
For an average of six years after undergoing gastric bypass surgery, severely obese patients not only lost a lot of weight, but also showed frequent remission and lower incidence of type 2 diabetes, plus lower rates of high blood pressure, abnormal cholesterol, and other cardiovascular risk factors, compared with a control group of similar patients who did not have the surgery. These were the findings of a JAMA study published on 19 September, that was led by researchers from the University of Utah School of Medicine, Salt Lake City, in the US.
Related posts:
- Diabetes Patients Who Undergo Bariatric Surgery Require Fewer Medications Type 2 diabetes patients who underwent bariatric surgery appear to require significantly less medication and incur considerably lower health costs, says a report published in this month’s issue of Archives of Surgery, a JAMA/Archives journal. Bariatric surgery is a surgical procedure on the stomach and/or intestines to help extremely obese people lose weight – it […]...
- Share of Cost, Chronic Gastroesophageal Reflux Disease – Medication And Surgery Equally Effective Laparoscopic antireflux surgery or taking proton pump inhibitor esomeprazole for chronic GERD (chronic gastroesophageal reflux disease) were both found to result in similar rates of disease remission of five years, researchers from Nantes University, France, reported in JAMA (Journal of the American Medical Association)....
- New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study: Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTC™ offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing […]...
- Modern Treatments For GERD Effective At Achieving Long-Term Remission For Most Patients In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA....
- GERD Treatments, Benefits And Risks – New Report New plain-language reports compare the risks and benefits of therapies for gastroesophageal reflux disease (GERD), a digestive condition that affects millions of individuals in the U.S., and can be treated with medications or surgery. The reports are from the U.S....
- Atrial Fibrillation Patients On Warfarin Have Low Risk of Residual Stroke A study published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals, reveals that patients with nonvalvular atrial fibrillation (AF) who take the stroke prevention drug warfarin have a low risk of stroke or non-central nervous system (CNS) embolism. AF is the most common heart rhythm disorder....
- Asthma UK Comment On: Drug Side Effect Linked With Increased Health Risks For Over 65s You may have seen some stories in the media today about a study into the risks of elderly people taking combinations of common medicines, some of which are used to treat asthma and allergies. Cher Piddock, Lead Asthma Nurse at Asthma UK, says: ‘This interesting study highlights the possible risks of combining several common medicines […]...
- Share of Cost, The Number Of U.S. Adults Treated For Diabetes More Than Doubled Between 1996 And 2007 Approximately 19 million U.S. adults reported receiving treatment for diabetes in 2007, more than double the 9 million who said they received care in 1996, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. AHRQ also found that between 1996 and 2007: — The number of people age 65 […]...
- Share of Cost, Poverty Leads To Poor Health – But Not For Everyone Share of Cost, Poverty Leads To Poor Health - But Not For Everyone...
- Greater Health Risks Faced By Asian Canadian LGB Teens Greater Health Risks Faced By Asian Canadian LGB Teens...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Unhealthy Behaviors More Prevalent In Survivors Of Multiple Cancers, Study Shows Unhealthy Behaviors More Prevalent In Survivors Of Multiple Cancers, Study Shows...
- Leftover Embryonic Cells Connect Gastric Reflux And Cancer The ultimate source of some cancers is embryonic cells. Research published in the June 24th Cell, a Cell Press publication, traces the precursor of deadly esophageal cancers to leftover embryonic cells found in all adults. Some people with gastric reflux disease have a greater risk of developing esophageal cancer....
- Airway Function Improves Following Anti-Reflux Surgery Both Before And After Lung Transplant Airway Function Improves Following Anti-Reflux Surgery Both Before And After Lung Transplant...
- Share of Cost, Light Drinking Can Raise Breast Cancer Likelihood Share of Cost, Light Drinking Can Raise Breast Cancer Likelihood...
Posted on Monday, May. 13th 2013 8:13 AM | by Share of Cost | in Share of Cost | No Comments »